ArticleInternational journal of medical sciences2024

CDK6 as a Biomarker for Immunotherapy, Drug Sensitivity, and Prognosis in Bladder Cancer: Bioinformatics and Immunohistochemical Analysis.

Xiaojie Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.